Financhill
Back

Syros Pharmaceuticals Stock Predictions

Syros Pharmaceuticals Stock Forecast

  • Is Syros Pharmaceuticals Stock Undervalued?
    The current Syros Pharmaceuticals [SYRS] share price is $0.21. The Score for SYRS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • SYRS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Syros Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Syros Pharmaceuticals Stock Rating

Data Unavailable

Syros Pharmaceuticals Stock Price History

Is SYRS stock going to rise?

  • The current trend is relatively stagnant and SYRS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
syros.com

52-Week Data

52-Week High:
8.17
52-Week Low:
0.18

Prediction Charts

Market Cap:
5.5M
Price in USD:
0.21
Volume:
2.8M
Beta:
1.37

Technical Analysis

SMA50:
1.20
SMA100:
1.77
SMA200:
3.65
52-Wk Change:
-96.23%

Stock Predictions

  • Is Syros Pharmaceuticals stock public?
    Yes, Syros Pharmaceuticals is a publicly traded company.
  • What is the Syros Pharmaceuticals stock quote today?
    The Syros Pharmaceuticals stock price is 0.21 USD today.
  • How to buy Syros Pharmaceuticals stock online?
    You can buy Syros Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 0.25 0.25 0.27 0.25
Dec-4 0.26 0.25 0.26 0.24
Dec-5 0.24 0.24 0.25 0.23
Dec-6 0.23 0.24 0.25 0.22
Dec-9 0.25 0.24 0.26 0.24
Dec-10 0.24 0.24 0.25 0.23
Dec-11 0.24 0.24 0.25 0.23
Dec-12 0.25 0.24 0.26 0.23
Dec-13 0.23 0.21 0.24 0.20
Dec-16 0.21 0.22 0.22 0.21
Dec-17 0.21 0.21 0.22 0.20
Dec-18 0.20 0.20 0.21 0.20
Dec-19 0.21 0.20 0.21 0.19
Dec-20 0.21 0.21 0.22 0.20

Syros Pharmaceuticals Earnings

Data Unavailable

Syros Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and a decrease next year of $0.85 per share.

* Syros Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.